Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C20H24O4 |
| Molecular Weight | 328.4022 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C1=C(O)C=CC(CC2=C(C)C=C(OCC(O)=O)C=C2C)=C1
InChI
InChIKey=QNAZTOHXCZPOSA-UHFFFAOYSA-N
InChI=1S/C20H24O4/c1-12(2)17-9-15(5-6-19(17)21)10-18-13(3)7-16(8-14(18)4)24-11-20(22)23/h5-9,12,21H,10-11H2,1-4H3,(H,22,23)
| Molecular Formula | C20H24O4 |
| Molecular Weight | 328.4022 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:25:25 UTC 2023
by
admin
on
Sat Dec 16 16:25:25 UTC 2023
|
| Record UNII |
XQ31741E9Q
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
334811
Created by
admin on Sat Dec 16 16:25:25 UTC 2023 , Edited by admin on Sat Dec 16 16:25:25 UTC 2023
|
||
|
NCI_THESAURUS |
C29703
Created by
admin on Sat Dec 16 16:25:25 UTC 2023 , Edited by admin on Sat Dec 16 16:25:25 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
XQ31741E9Q
Created by
admin on Sat Dec 16 16:25:25 UTC 2023 , Edited by admin on Sat Dec 16 16:25:25 UTC 2023
|
PRIMARY | |||
|
DB07425
Created by
admin on Sat Dec 16 16:25:25 UTC 2023 , Edited by admin on Sat Dec 16 16:25:25 UTC 2023
|
PRIMARY | |||
|
C81539
Created by
admin on Sat Dec 16 16:25:25 UTC 2023 , Edited by admin on Sat Dec 16 16:25:25 UTC 2023
|
PRIMARY | |||
|
UU-36
Created by
admin on Sat Dec 16 16:25:25 UTC 2023 , Edited by admin on Sat Dec 16 16:25:25 UTC 2023
|
PRIMARY | |||
|
211110-63-3
Created by
admin on Sat Dec 16 16:25:25 UTC 2023 , Edited by admin on Sat Dec 16 16:25:25 UTC 2023
|
PRIMARY | |||
|
CHEMBL107400
Created by
admin on Sat Dec 16 16:25:25 UTC 2023 , Edited by admin on Sat Dec 16 16:25:25 UTC 2023
|
PRIMARY | |||
|
9089
Created by
admin on Sat Dec 16 16:25:25 UTC 2023 , Edited by admin on Sat Dec 16 16:25:25 UTC 2023
|
PRIMARY | |||
|
DTXSID60891557
Created by
admin on Sat Dec 16 16:25:25 UTC 2023 , Edited by admin on Sat Dec 16 16:25:25 UTC 2023
|
PRIMARY | |||
|
9862248
Created by
admin on Sat Dec 16 16:25:25 UTC 2023 , Edited by admin on Sat Dec 16 16:25:25 UTC 2023
|
PRIMARY | |||
|
300000034431
Created by
admin on Sat Dec 16 16:25:25 UTC 2023 , Edited by admin on Sat Dec 16 16:25:25 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
Binds selectively to the main hepatic form of thyroid hormone (TH) receptor, TRβ1, compared to TRα1, which is principally responsible for thyrotoxic effects on heart, muscle and bone.
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
